Back to search
FDAFDA · Food and drugs·Recall number Z-0856-2022

Silatrix Oral Gel Polymerized Sucralfate Gel 10% (1 gm/10 gm

Published April 13, 2022 · Recall initiated: February 21, 2022

Summary

FDA records medical device Class II recall Z-0856-2022, published April 13, 2022 and initiated February 21, 2022. Recalling firm: SA3, LLC; Status: Terminated; Reported quantity: 156 units; Lot: Product Number: 69420-8351-1 Lot Number: U701SF1 UDI Code: N/A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to failure of microbial testing for total aerobic microbial count (TAMC).

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SA3, LLC
Distributor
U.S. Nationwide distribution in the states of CA, FL and GA.
Lot
Product Number: 69420-8351-1 Lot Number: U701SF1 UDI Code: N/A
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Silatrix Oral Gel Polymerized Sucralfate Gel 10% (1 gm/10 gm recalled?

Yes. FDA published recall Z-0856-2022 on April 13, 2022. Reported hazard: Due to failure of microbial testing for total aerobic microbial count (TAMC).

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail